Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

75%

9 trials in Phase 3/4

Results Transparency

78%

7 of 9 completed with results

Key Signals

7 with results90% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (1)
P 2 (2)
P 3 (9)

Trial Status

Completed9
Unknown2
Terminated1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (12)

Research Network

Activity Timeline